Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers
- 11 August 2003
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 47 (8) , 1020-1030
Abstract
Background: Muscle pain is a major clinical problem but the underlying mechanisms and its pharmacological modulation need further investigation. This study on 15 volunteers evaluates if two experimental muscle pain models are sensitive to µ‐receptor agonists and to an N‐methyl‐D‐aspartate (NMDA)‐receptor antagonist.Methods: In the left tibialis anterior, intramuscular electrical (IMES) pain thresholds were determined for single (SPTmuscle) and five (RPTmuscle) repeated stimuli. Also pain to suprathreshold stimulation at 150% of RPTmuscle, 10 s, was assessed on a visual analog scale (VAS) as AUCimes (area under the VAS curve). In the right TA muscle, pain intensity on infusion of 0.5 ml of hypertonic saline, 5% (AUCsaline) and pain distribution indicated as local and referred were evaluated. Pain variables were assessed before, during and after intravenous infusions of morphine (10 µg kg−1 min−1, 10 min), alfentanil (target‐controlled infusion, plasma concentration; 60 ng ml−1, 60 min) and ketamine (10 µg kg−1 min−1, 60 min). All data were normalized to baseline pain values (before drug infusions were initiated) and compared with placebo (midazolam, 2 µg kg−1 min−1, 10 min).Results: SPTmuscle increased (log mean values ± SD, mA) with morphine (0.11 ± 0.17, P < 0.05), alfentanil (0.28 ± 0.24, P < 0.001) and ketamine (0.19 ± 0.18, P < 0.01) as compared with placebo (−0.03 ± 0.12). Alfentanil and ketamine also increased RPTmuscle (0.25 ± 0.21, P < 0.01 and 0.21 ± 0.19, P < 0.05, respectively) as compared with placebo (0.00 ± 0.17). Pain to IMES (AUCimes) was reduced (median values [25th−75th percentiles], cm × s) by alfentanil and ketamine (−19.7 [−14.6 – −29.6] and−12.8 [−8.3 – −27.8], P < 0.05, respectively) vs. placebo (−0.8 [1.6 – −12.3]). Similar drug effects were seen when pain to infusion of hypertonic saline (AUCsaline) was assessed (alfentanil:−388 [−99 – −677] and ketamine:−326 [−227 – −573], P < 0.05 compared with placebo: 150 [449–−240]). Ketamine also reduced the size of the local pain area (−58.4 [−21.2 – −176.1], < 0.05) as compared with placebo (−0.4 [70.6 – −13.4]). The frequency of referred pain was also lower when ketamine was given (3/13, P < 0.05) vs. placebo (9/14).Conclusion: The study demonstrates that experimental muscle pain induced in humans by electrical stimulation and infusion of hypertonic saline is sensitive to pharmacological modulation similar to preclinical animal tests and clinical trials. The data suggest that these models can be valuable tools in analgesic drug development.Keywords
This publication has 21 references indexed in Scilit:
- Experimental Muscle Pain: A Quantitative Study of Local and Referred Pain in Humans Following Injection of Hypertonic SalineJournal of Musculoskeletal Pain, 1997
- Quantification of local and referred muscle pain in humans after sequential i.m. injections of hypertonic salinePain, 1997
- In vivo model of muscle pain: Quantification of intramuscular chemical, electrical, and pressure changes associated with saline-induced muscle pain in humansPain, 1997
- The Effect of N-Methyl-D-aspartate Antagonist (Ketamine) on Single and Repeated Nociceptive StimuliAnesthesia & Analgesia, 1995
- Pain Analysis in Patients with Fibromyalgia:Effects of intravenous morphine, lidocaine, and ketamineScandinavian Journal of Rheumatology, 1995
- The Influence of Adenosine, Ketamine, and Morphine on Experimentally Induced Ischemic Pain in Healthy VolunteersAnesthesia & Analgesia, 1994
- Computer-controlled Infusion of Alfentanil for Postoperative AnalgesiaAnesthesiology, 1993
- Pharmacological Mechanisms of Opioid AnalgesicsClinical Neuropharmacology, 1993
- The contribution of pharmacokinetics and pharmacodynamics to clinical anaesthesia careCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1988
- Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following c fibre stimulation.Neuropharmacology, 1987